Back
Reviva Pharmaceuticals Holdings 10K Form
Sell
14
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.72
Seasonality Move:
-41.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RVPH News And Ratings
See the #1 stock for the next 7 days that we like better than RVPH
RVPH Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-8.88M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.20 |
| Price / Book: | 8.35 |
Profitability
| EPS (TTM): | -1.64000 |
|---|---|
| Net Income (TTM): | $-39.26M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Reviva Pharmaceuticals Holdings Earnings Forecast
Key Reviva Pharmaceuticals Holdings Financial Ratios
- The Interest Expense is -0.03% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Reviva Pharmaceuticals Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RVPH |
| Website: | revivapharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RVPH Technical Analysis vs Fundamental Analysis
Sell
14
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Is Reviva Pharmaceuticals Holdings a Buy or a Sell?
-
Reviva Pharmaceuticals Holdings stock is rated a Sell
The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.71. The Score for RVPH is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.